146 related articles for article (PubMed ID: 28785574)
21. Factors that predict treatment choice and satisfaction with the decision in men with localized prostate cancer.
Berry DL; Ellis WJ; Russell KJ; Blasko JC; Bush N; Blumenstein B; Lange PH
Clin Genitourin Cancer; 2006 Dec; 5(3):219-26. PubMed ID: 17239276
[TBL] [Abstract][Full Text] [Related]
22. Decision-making strategies for patients with localized prostate cancer.
Diefenbach MA; Dorsey J; Uzzo RG; Hanks GE; Greenberg RE; Horwitz E; Newton F; Engstrom PF
Semin Urol Oncol; 2002 Feb; 20(1):55-62. PubMed ID: 11828358
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular comorbidity and treatment regret in men with recurrent prostate cancer.
Nguyen PL; Chen MH; Hoffman KE; Chen RC; Hu JC; Bennett CL; Kattan MW; Sartor O; Stein K; D'Amico AV
BJU Int; 2012 Jul; 110(2):201-5. PubMed ID: 22085233
[TBL] [Abstract][Full Text] [Related]
24. 'It's not like you just had a heart attack': decision-making about active surveillance by men with localized prostate cancer.
Volk RJ; McFall SL; Cantor SB; Byrd TL; Le YC; Kuban DA; Mullen PD
Psychooncology; 2014 Apr; 23(4):467-72. PubMed ID: 24243777
[TBL] [Abstract][Full Text] [Related]
25. Implementation of a patient decision aid for men with localized prostate cancer: evaluation of patient outcomes and practice variation.
Stacey D; Taljaard M; Smylie J; Boland L; Breau RH; Carley M; Jana K; Peckford L; Blackmore T; Waldie M; Wu RC; Legare F
Implement Sci; 2016 Jul; 11(1):87. PubMed ID: 27368830
[TBL] [Abstract][Full Text] [Related]
26. Treatment decision-making strategies and influences in patients with localized prostate carcinoma.
Gwede CK; Pow-Sang J; Seigne J; Heysek R; Helal M; Shade K; Cantor A; Jacobsen PB
Cancer; 2005 Oct; 104(7):1381-90. PubMed ID: 16080181
[TBL] [Abstract][Full Text] [Related]
27. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening.
Yan Y; Carvalhal GF; Catalona WJ; Young JD
Cancer; 2000 Mar; 88(5):1122-30. PubMed ID: 10699903
[TBL] [Abstract][Full Text] [Related]
28. Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.
Fitch M; Pang K; Ouellet V; Loiselle C; Alibhai S; Chevalier S; Drachenberg DE; Finelli A; Lattouf JB; Sutcliffe S; So A; Tanguay S; Saad F; Mes-Masson AM
BMC Urol; 2017 Oct; 17(1):98. PubMed ID: 29078772
[TBL] [Abstract][Full Text] [Related]
29. Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era.
Carter CA; Donahue T; Sun L; Wu H; McLeod DG; Amling C; Lance R; Foley J; Sexton W; Kusuda L; Chung A; Soderdahl D; Jackmaan S; Moul JW
J Clin Oncol; 2003 Nov; 21(21):4001-8. PubMed ID: 14581423
[TBL] [Abstract][Full Text] [Related]
30. What influences men's decision to have a prostate-specific antigen test? A qualitative study.
Rai T; Clements A; Bukach C; Shine B; Austoker J; Watson E
Fam Pract; 2007 Sep; 24(4):365-71. PubMed ID: 17644829
[TBL] [Abstract][Full Text] [Related]
31. Is "Active Surveillance" an Acceptable Alternative?: A Qualitative Study of Couples' Decision Making about Early-Stage, Localized Prostate Cancer.
Le YL; McFall SL; Byrd TL; Volk RJ; Cantor SB; Kuban DA; Mullen PD
Narrat Inq Bioeth; 2016; 6(1):51-61. PubMed ID: 27346824
[TBL] [Abstract][Full Text] [Related]
32. The Influence of Psychosocial Constructs on the Adherence to Active Surveillance for Localized Prostate Cancer in a Prospective, Population-based Cohort.
Lang MF; Tyson MD; Alvarez JR; Koyama T; Hoffman KE; Resnick MJ; Cooperberg MR; Wu XC; Chen V; Paddock LE; Hamilton AS; Hashibe M; Goodman M; Greenfield S; Kaplan SH; Stroup A; Penson DF; Barocas DA
Urology; 2017 May; 103():173-178. PubMed ID: 28189554
[TBL] [Abstract][Full Text] [Related]
33. Preliminary treatment considerations among men with newly diagnosed prostate cancer.
Zeliadt SB; Moinpour CM; Blough DK; Penson DF; Hall IJ; Smith JL; Ekwueme DU; Thompson IM; Keane TE; Ramsey SD
Am J Manag Care; 2010 May; 16(5):e121-30. PubMed ID: 20455638
[TBL] [Abstract][Full Text] [Related]
34. Patient reported factors influencing the decision-making process of men with localised prostate cancer when considering Active Surveillance-A systematic review and thematic synthesis.
Cunningham M; Murphy M; Sweeney P; Richards HL
Psychooncology; 2022 Mar; 31(3):388-404. PubMed ID: 34605104
[TBL] [Abstract][Full Text] [Related]
35. Decision analysis using individual patient preferences to determine optimal treatment for localized prostate cancer.
Sommers BD; Beard CJ; D'Amico AV; Dahl D; Kaplan I; Richie JP; Zeckhauser RJ
Cancer; 2007 Nov; 110(10):2210-7. PubMed ID: 17893907
[TBL] [Abstract][Full Text] [Related]
36. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
37. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer.
Davison BJ; So AI; Goldenberg SL
BJU Int; 2007 Oct; 100(4):780-5. PubMed ID: 17578466
[TBL] [Abstract][Full Text] [Related]
38. The application of the heuristic-systematic processing model to treatment decision making about prostate cancer.
Steginga SK; Occhipinti S
Med Decis Making; 2004; 24(6):573-83. PubMed ID: 15534339
[TBL] [Abstract][Full Text] [Related]
39. Treatment decision-making by men with localized prostate cancer: the influence of personal factors.
Berry DL; Ellis WJ; Woods NF; Schwien C; Mullen KH; Yang C
Urol Oncol; 2003; 21(2):93-100. PubMed ID: 12856636
[TBL] [Abstract][Full Text] [Related]
40. Social and clinical predictors of prostate cancer treatment decisions among men in South Carolina.
Wagner SE; Drake BF; Elder K; Hébert JR
Cancer Causes Control; 2011 Nov; 22(11):1597-606. PubMed ID: 21877121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
